Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway

Phytomedicine. 2020 Dec:79:153341. doi: 10.1016/j.phymed.2020.153341. Epub 2020 Sep 19.

Abstract

Background: Curcumin (CUR) is a natural diarylheptanoid with marked anti-tumor activities. Recent investigations demonstrate that CUR combines with some other phytochemicals exerts advantages over its single application manifested as lower toxicity, higher efficacy or more significant reversal of multidrug resistance.

Purpose: This study aimed to elucidate a new biflavonoid (wikstroflavone B, WFB) isolated from Wikstroemia indica and to assess the synergistic inhibition of combined CUR and WFB (CUR/WFB) on human nasopharyngeal carcinoma (NPC) cell lines proliferation and metastasis.

Methods: WFB was obtained through sequential chromatographic methods including silica gel, Sephadex LH-20 and preparative HPLC. Its structure was determined by HRESIMS, 1D and 2D NMR spectroscopic analysis. The absolute configuration of WFB was assigned through comparison of experimental and calculated optical rotation (OR) values. Changes in cellular viability, migration and invasion were assessed by MTT, colony formation, wound healing and Transwell assays. The nature of synergistic interaction of CUR/WFB was determined through the combination index (CI) method under the median-effect analysis. Expression levels of indicated mRNAs and proteins were measured by qRT-PCR and Western blotting assays, respectively.

Results: WFB was isolated and structural elucidated. Compared with CUR or WFB used alone, CUR/WFB treatment inhibited more effectively on the cell viability, colony formation, cell migration and invasion. Both CI and dose reduction index (DRI) values indicated the significant synergistic effects existed between CUR and WFB. Besides, CUR/WFB showed the marked modulation on the genes involved in cell proliferation (survivin, cyclin D1, p53 and p21) and metastasis (MMP-2, MMP-9 and FAK). CUR/WFB treatment was also found to restrain the phosphorylation of FAK and STAT3 proteins. When pretreatment with a FAK inhibitor, the cell viability and metastasis were significantly attenuated.

Conclusion: The results indicate that WFB can synergistically increase the inhibitory effects of CUR on NPC cells proliferation and metastasis, and these findings may afford a rational approach for developing the antitumor medications.

Keywords: Curcumin; FAK/STAT3 signaling pathway; biflavonoid; nasopharyngeal carcinoma; synergism.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Biflavonoids / administration & dosage
  • Biflavonoids / chemistry
  • Biflavonoids / isolation & purification*
  • Biflavonoids / pharmacology
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Curcumin / administration & dosage
  • Curcumin / pharmacology
  • Focal Adhesion Kinase 1 / metabolism
  • Humans
  • Matrix Metalloproteinases / metabolism
  • Molecular Structure
  • Nasopharyngeal Carcinoma / drug therapy*
  • Nasopharyngeal Carcinoma / metabolism
  • Nasopharyngeal Carcinoma / pathology
  • Nasopharyngeal Neoplasms / drug therapy*
  • Nasopharyngeal Neoplasms / metabolism
  • Nasopharyngeal Neoplasms / pathology
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Wikstroemia / chemistry

Substances

  • Biflavonoids
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Focal Adhesion Kinase 1
  • PTK2 protein, human
  • Matrix Metalloproteinases
  • Curcumin